Anxiety Disorders

Panel Backs Medical Marijuana for PTSD in Illinois

U.S. Drug 'Czar' Says Addiction, Health Concerns With Pot as Legalization Continues
U.S. Drug ‘Czar’ Says Addiction, Health Concerns With Pot as Legalization Continues
The Illinois Medical Cannabis Advisory Board, however, rejected cannabis as a treatment for anxiety.

An Illinois panel Monday recommended allowing medical marijuana to treat post-traumatic stress disorder, anorexia and migraine headaches, but rejected its use for anxiety and diabetes.

The Illinois Medical Cannabis Advisory Board supported the drug’s availability for 11 new medical conditions in all, including chronic post-surgical pain, osteoarthritis and irritable bowel syndrome.

The recommendations, if approved by the Illinois Department of Public Health, would significantly increase the list of conditions for which medical pot can be accessed. As it stands, sufferers of about three-dozen disorders and diseases, including AIDS, cancer and lupus, can be eligible for medical marijuana — though a series of delays has so far rendered medicinal pot unavailable in the marketplace.

Related Content

READ FULL ARTICLE Curated publisher From Chicago Tribune